IntelGenx Grants Stock Options
(firmenpresse) - SAINT-LAURENT, CANADA -- (Marketwired) -- 01/19/17 -- IntelGenx Technologies Corp. ("IntelGenx", or the "Company") (TSX VENTURE: IGX)(OTCQX: IGXT) announced today that the Company''s board of directors granted options to acquire a total of 300,000 common shares under the 2016 Stock Option Plan.
Of the total stock options granted, 50,000 were granted to each of the following non-employee directors Bernard Boudreau, John Marinucci, Ian Troup, Bernd Melchers, Clemens Mayr and Mark Nawacki. The options were granted as part of the annual compensation for non-employee directors. The options have an exercise price of US$0.89 (CAD$1.16), vest immediately, and expire on January 17, 2027.
About IntelGenx:
IntelGenx is a leading oral drug delivery company primarily focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm™ technology platform. Established in 2003, the Montreal-based company is listed on the TSX-V and OTC-QX.
IntelGenx highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. IntelGenx state-of-the-art manufacturing facility, established for the VersaFilm™ technology platform, supports lab-scale to pilot and commercial-scale production, offering full service capabilities to our clients. More information is available about the company at: .
Each of the TSX Venture Exchange and OTCQX has neither approved nor disapproved the contents of this press release.
Source: IntelGenx Technologies Corp.
Contacts:
IntelGenx Technologies Corp.
Ingrid Zerbe
Corporate Secretary
514-331-7440
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 19.01.2017 - 15:15 Uhr
Sprache: Deutsch
News-ID 1481528
Anzahl Zeichen: 2559
contact information:
Contact person:
Town:
SAINT-LAURENT, CANADA
Phone:
Kategorie:
Health & Nutrition
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 338 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"IntelGenx Grants Stock Options
"
steht unter der journalistisch-redaktionellen Verantwortung von
IntelGenx Technologies Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
